BIOS Fund I LP 13D/13G Filings for Rein Therapeutics Inc. (RNTX)

BIOS Fund I LP 13D and 13G filings for Rein Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-05-08
11:33 am
Purchase		2026-05-0613GREIN THERAPEUTICS INC
RNTX		BIOS Fund I LP7,797,502
9.990%		7,255,246increase
(+1337.97%)		Filing
2023-11-13
5:08 pm
Purchase		2023-10-3113GREIN THERAPEUTICS INC
RNTX		BIOS Fund I LP542,256
9.990%		542,256increase
(New Position)		Filing